Harbor Capital Advisors, Inc. Aura Biosciences, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $2.19 Billion
- Q1 2025
A detailed history of Harbor Capital Advisors, Inc. transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 25,741 shares of AURA stock, worth $138,486. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,741Holding current value
$138,486% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AURA
# of Institutions
97Shares Held
39.8MCall Options Held
1.9KPut Options Held
31K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$37.2 Million2.75% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$26.3 Million0.07% of portfolio
-
Eventide Asset Management, LLC Boston, MA4.08MShares$22 Million0.64% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$16.4 Million4.98% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$16.2 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $157M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...